BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21733355)

  • 1. Tissue expression of the hepatitis C virus NS3 protein does not correlate with histological or clinical features in patients with chronic hepatitis C.
    Liao WH; Tung SY; Shen CH; Lee KF; Wu CS
    Chang Gung Med J; 2011; 34(3):260-7. PubMed ID: 21733355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
    Rahbin N; Frelin L; Aleman S; Hultcrantz R; Sällberg M; Brenndörfer ED
    Biochem Biophys Res Commun; 2013 Mar; 433(1):31-5. PubMed ID: 23454379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
    McCormick SE; Goodman ZD; Maydonovitch CL; Sjogren MH
    Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of hepatitis C virus (HCV) in liver biopsies of hepatitis C patients.
    Syed SI; Sadiq S
    J Pak Med Assoc; 2011 Dec; 61(12):1198-201. PubMed ID: 22355966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
    Schmidt WN; Stapleton JT; LaBrecque DR; Mitros FA; Kirby PA; Phillips MJ; Brashear DL
    Hepatology; 2000 Mar; 31(3):737-44. PubMed ID: 10706566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.
    Pal S; Shuhart MC; Thomassen L; Emerson SS; Su T; Feuerborn N; Kae J; Gretch DR
    J Virol; 2006 Mar; 80(5):2280-90. PubMed ID: 16474135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
    Larghi A; Tagger A; Crosignani A; Ribero ML; Bruno S; Portera G; Battezzati PM; Maggioni M; Fasola M; Zuin M; Podda M
    J Med Virol; 1998 May; 55(1):7-11. PubMed ID: 9580879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
    Maylin S; Laouénan C; Martinot-Peignoux M; Panhard X; Lapalus M; Nicolas-Chanoine MH; Bedossa P; Asselah T; Marcellin P
    J Clin Virol; 2012 Jan; 53(1):43-7. PubMed ID: 22099210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
    Papadopoulos N; Manolakopoulos S; Deutsch M; Mela M; Christidou A; Katoglou A; Tzourmakliotis D; Papatheodoridis GV
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):587-93. PubMed ID: 23426269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum.
    Xie L; Wu XD; Huang DZ; Chen HL; He LX; Wang J; Han DK
    Chin Med J (Engl); 2007 Feb; 120(4):294-9. PubMed ID: 17374280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular localization of NS3 and C proteins in chronic hepatitis C.
    Kasprzak A; Seidel J; Biczysko W; Wysocki J; Spachacz R; Zabel M
    Liver Int; 2005 Aug; 25(4):896-903. PubMed ID: 15998442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.